ActivityPub Viewer

A small tool to view real-world ActivityPub objects as JSON! Enter a URL or username from Mastodon or a similar service below, and we'll send a request with the right Accept header to the server to view the underlying object.

Open in browser →
{ "@context": [ "https://www.w3.org/ns/activitystreams", { "ostatus": "http://ostatus.org#", "atomUri": "ostatus:atomUri", "inReplyToAtomUri": "ostatus:inReplyToAtomUri", "conversation": "ostatus:conversation", "sensitive": "as:sensitive", "toot": "http://joinmastodon.org/ns#", "votersCount": "toot:votersCount", "blurhash": "toot:blurhash", "focalPoint": { "@container": "@list", "@id": "toot:focalPoint" }, "Hashtag": "as:Hashtag" } ], "id": "https://pubeurope.com/users/europesays/statuses/114574232970779435", "type": "Note", "summary": null, "inReplyTo": null, "published": "2025-05-26T12:54:12Z", "url": "https://pubeurope.com/@europesays/114574232970779435", "attributedTo": "https://pubeurope.com/users/europesays", "to": [ "https://www.w3.org/ns/activitystreams#Public" ], "cc": [ "https://pubeurope.com/users/europesays/followers" ], "sensitive": false, "atomUri": "https://pubeurope.com/users/europesays/statuses/114574232970779435", "inReplyToAtomUri": null, "conversation": "tag:pubeurope.com,2025-05-26:objectId=2834518:objectType=Conversation", "content": "<p><a href=\"https://www.europesays.com/2110103/\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" translate=\"no\"><span class=\"invisible\">https://www.</span><span class=\"\">europesays.com/2110103/</span><span class=\"invisible\"></span></a> Australia Delivers Certainty for US Biotechs in 2025: Avance Clinical Offers Fast Start-Up, Regulatory Predictability, and R&amp;D Rebates #2025: Avance <a href=\"https://pubeurope.com/tags/And\" class=\"mention hashtag\" rel=\"tag\">#<span>And</span></a> <a href=\"https://pubeurope.com/tags/australia\" class=\"mention hashtag\" rel=\"tag\">#<span>australia</span></a> <a href=\"https://pubeurope.com/tags/Biotechs\" class=\"mention hashtag\" rel=\"tag\">#<span>Biotechs</span></a> <a href=\"https://pubeurope.com/tags/Certainty\" class=\"mention hashtag\" rel=\"tag\">#<span>Certainty</span></a> <a href=\"https://pubeurope.com/tags/Clinical\" class=\"mention hashtag\" rel=\"tag\">#<span>Clinical</span></a> <a href=\"https://pubeurope.com/tags/delivers\" class=\"mention hashtag\" rel=\"tag\">#<span>delivers</span></a> <a href=\"https://pubeurope.com/tags/FAST\" class=\"mention hashtag\" rel=\"tag\">#<span>FAST</span></a> <a href=\"https://pubeurope.com/tags/for\" class=\"mention hashtag\" rel=\"tag\">#<span>for</span></a> <a href=\"https://pubeurope.com/tags/in\" class=\"mention hashtag\" rel=\"tag\">#<span>in</span></a> <a href=\"https://pubeurope.com/tags/Offers\" class=\"mention hashtag\" rel=\"tag\">#<span>Offers</span></a> <a href=\"https://pubeurope.com/tags/Predictability\" class=\"mention hashtag\" rel=\"tag\">#<span>Predictability</span></a> <a href=\"https://pubeurope.com/tags/r\" class=\"mention hashtag\" rel=\"tag\">#<span>r</span></a>&amp;d <a href=\"https://pubeurope.com/tags/Rebates\" class=\"mention hashtag\" rel=\"tag\">#<span>Rebates</span></a> <a href=\"https://pubeurope.com/tags/regulatory\" class=\"mention hashtag\" rel=\"tag\">#<span>regulatory</span></a> <a href=\"https://pubeurope.com/tags/StartUp\" class=\"mention hashtag\" rel=\"tag\">#<span>StartUp</span></a> <a href=\"https://pubeurope.com/tags/US\" class=\"mention hashtag\" rel=\"tag\">#<span>US</span></a></p>", "contentMap": { "en": "<p><a href=\"https://www.europesays.com/2110103/\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" translate=\"no\"><span class=\"invisible\">https://www.</span><span class=\"\">europesays.com/2110103/</span><span class=\"invisible\"></span></a> Australia Delivers Certainty for US Biotechs in 2025: Avance Clinical Offers Fast Start-Up, Regulatory Predictability, and R&amp;D Rebates #2025: Avance <a href=\"https://pubeurope.com/tags/And\" class=\"mention hashtag\" rel=\"tag\">#<span>And</span></a> <a href=\"https://pubeurope.com/tags/australia\" class=\"mention hashtag\" rel=\"tag\">#<span>australia</span></a> <a href=\"https://pubeurope.com/tags/Biotechs\" class=\"mention hashtag\" rel=\"tag\">#<span>Biotechs</span></a> <a href=\"https://pubeurope.com/tags/Certainty\" class=\"mention hashtag\" rel=\"tag\">#<span>Certainty</span></a> <a href=\"https://pubeurope.com/tags/Clinical\" class=\"mention hashtag\" rel=\"tag\">#<span>Clinical</span></a> <a href=\"https://pubeurope.com/tags/delivers\" class=\"mention hashtag\" rel=\"tag\">#<span>delivers</span></a> <a href=\"https://pubeurope.com/tags/FAST\" class=\"mention hashtag\" rel=\"tag\">#<span>FAST</span></a> <a href=\"https://pubeurope.com/tags/for\" class=\"mention hashtag\" rel=\"tag\">#<span>for</span></a> <a href=\"https://pubeurope.com/tags/in\" class=\"mention hashtag\" rel=\"tag\">#<span>in</span></a> <a href=\"https://pubeurope.com/tags/Offers\" class=\"mention hashtag\" rel=\"tag\">#<span>Offers</span></a> <a href=\"https://pubeurope.com/tags/Predictability\" class=\"mention hashtag\" rel=\"tag\">#<span>Predictability</span></a> <a href=\"https://pubeurope.com/tags/r\" class=\"mention hashtag\" rel=\"tag\">#<span>r</span></a>&amp;d <a href=\"https://pubeurope.com/tags/Rebates\" class=\"mention hashtag\" rel=\"tag\">#<span>Rebates</span></a> <a href=\"https://pubeurope.com/tags/regulatory\" class=\"mention hashtag\" rel=\"tag\">#<span>regulatory</span></a> <a href=\"https://pubeurope.com/tags/StartUp\" class=\"mention hashtag\" rel=\"tag\">#<span>StartUp</span></a> <a href=\"https://pubeurope.com/tags/US\" class=\"mention hashtag\" rel=\"tag\">#<span>US</span></a></p>" }, "attachment": [ { "type": "Document", "mediaType": "image/jpeg", "url": "https://media.pubeurope.com/media_attachments/files/114/574/232/951/135/092/original/9698f850616055b9.jpg", "name": "Australia Delivers Certainty for US Biotechs in 2025: Avance Clinical Offers Fast Start-Up, Regulatory Predictability, and R&D Rebates", "blurhash": "UMRpIGR:~Tt4tSs+-jWYRkR.M|jY?EobRoa~", "width": 1200, "height": 644 } ], "tag": [ { "type": "Hashtag", "href": "https://pubeurope.com/tags/and", "name": "#and" }, { "type": "Hashtag", "href": "https://pubeurope.com/tags/australia", "name": "#australia" }, { "type": "Hashtag", "href": "https://pubeurope.com/tags/biotechs", "name": "#biotechs" }, { "type": "Hashtag", "href": "https://pubeurope.com/tags/certainty", "name": "#certainty" }, { "type": "Hashtag", "href": "https://pubeurope.com/tags/clinical", "name": "#clinical" }, { "type": "Hashtag", "href": "https://pubeurope.com/tags/delivers", "name": "#delivers" }, { "type": "Hashtag", "href": "https://pubeurope.com/tags/fast", "name": "#fast" }, { "type": "Hashtag", "href": "https://pubeurope.com/tags/for", "name": "#for" }, { "type": "Hashtag", "href": "https://pubeurope.com/tags/in", "name": "#in" }, { "type": "Hashtag", "href": "https://pubeurope.com/tags/offers", "name": "#offers" }, { "type": "Hashtag", "href": "https://pubeurope.com/tags/predictability", "name": "#predictability" }, { "type": "Hashtag", "href": "https://pubeurope.com/tags/r", "name": "#r" }, { "type": "Hashtag", "href": "https://pubeurope.com/tags/rebates", "name": "#rebates" }, { "type": "Hashtag", "href": "https://pubeurope.com/tags/regulatory", "name": "#regulatory" }, { "type": "Hashtag", "href": "https://pubeurope.com/tags/startup", "name": "#startup" }, { "type": "Hashtag", "href": "https://pubeurope.com/tags/us", "name": "#us" } ], "replies": { "id": "https://pubeurope.com/users/europesays/statuses/114574232970779435/replies", "type": "Collection", "first": { "type": "CollectionPage", "next": "https://pubeurope.com/users/europesays/statuses/114574232970779435/replies?only_other_accounts=true&page=true", "partOf": "https://pubeurope.com/users/europesays/statuses/114574232970779435/replies", "items": [] } }, "likes": { "id": "https://pubeurope.com/users/europesays/statuses/114574232970779435/likes", "type": "Collection", "totalItems": 0 }, "shares": { "id": "https://pubeurope.com/users/europesays/statuses/114574232970779435/shares", "type": "Collection", "totalItems": 0 } }